GLP-1 Market
LLY $1364.73 ▼ -3.8% NVO $40.30 ▼ -4.5% PFE $29.88 ▼ -3.0% VKTX $25.79 ▼ -7.8% KLRA $12.17 ▼ -4.9% GPCR $19.08 ▼ -6.3% RHHBY $59.45 ▼ -2.4%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Metformin Hcl Tab

Company
American University of Beirut Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 6, 2026

Find a Clinical Trial Near Me

See recruiting studies for Metformin Hcl Tab and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04578652

    Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

    Not yet reported University of Alberta 90 participants Est. completion 2027-02 1 site
    Other conditions: Obesity, Childhood, Insulin Resistance
    View official trial listing →
  • Recruiting NCT NCT06142656

    Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

    Not yet reported, Not yet reported October 6 University 60 participants Est. completion 2026-02-01 1 site
    Other conditions: Poly Cystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06948825

    Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

    Not yet reported George Washington University 60 participants Est. completion 2026-11 1 site
    Other conditions: Weight Loss, Gestational Diabetes Mellitus in Pregnancy, Postpartum Care
    View official trial listing →
  • Completed NCT NCT02960711

    Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1600 participants Est. completion 2019-07 1 site
    Metabolic syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT04194424

    A Multidisciplinary Weight Loss Program at AUB-MC

    Not yet reported American University of Beirut Medical Center 20 participants Est. completion 2027-09-15 1 site Stand-alone
    Other conditions: Obesity, Weight Loss
    View official trial listing →
  • Active, not recruiting NCT NCT05893225

    Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

    Not yet reported University Hospital, Antwerp 120 participants Est. completion 2027-02-28 5 sites
    Other conditions: Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Metformin Hcl Tab, Metformin Hcl 850Mg Tab

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.